Prokidney (PROK) EBIT (2021 - 2026)
Prokidney (PROK) reported EBIT of -$44.9 million for Q1 2026, down 8.57% year-over-year from -$49.1 million in Q1 2025, and down 151.13% quarter-over-quarter from $87.9 million in Q4 2025.
Prokidney (PROK) EBIT (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of EBIT data on file, last reported at -$44.9 million in Q1 2026.
- EBIT for Q1 2026 came in at -$44.9 million, down 8.57% year-over-year; the trailing twelve-month figure through Mar 2026 was -$35.3 million (up 80.92% YoY), and the FY2025 annual result was -$31.8 million, up 82.71% from the prior year.
- EBIT declined to -$44.9 million in Q1 2026 per PROK's latest filing, from $87.9 million in the prior quarter.
- Over five years, EBIT peaked at $87.9 million in Q4 2025 and troughed at -$66.5 million in Q1 2022.
- A 5-year average of -$33.2 million and a median of -$40.1 million in 2024 frame the typical range for EBIT.
- The sharpest annual moves came in 2022 and 2025: EBIT plunged 1282455.0% in 2022, then surged 270.41% in 2025.
- A 5-year view of EBIT shows it stood at -$30.2 million in 2022, then advanced by 19.93% to -$24.2 million in 2023, then sank by 113.02% to -$51.6 million in 2024, then surged by 270.41% to $87.9 million in 2025, then plunged by 151.13% to -$44.9 million in 2026.
- Business Quant data shows PROK's EBIT at -$44.9 million in Q1 2026, $87.9 million in Q4 2025, and -$38.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | -44.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.93 Mn |
| Dec 31, 2025 | 87.88 Mn |
| Sep 30, 2025 | -38.54 Mn |
| Jun 30, 2025 | -39.71 Mn |
| Mar 31, 2025 | -41.39 Mn |
| Dec 31, 2024 | -51.57 Mn |
| Sep 30, 2024 | -48.97 Mn |
| Jun 30, 2024 | -43.06 Mn |
| Mar 31, 2024 | -40.08 Mn |
| Dec 31, 2023 | -24.21 Mn |
| Sep 30, 2023 | -46.62 Mn |
| Jun 30, 2023 | -39.82 Mn |
| Mar 31, 2023 | -40.88 Mn |
| Dec 31, 2022 | -30.24 Mn |
| Sep 30, 2022 | -35.57 Mn |
| Jun 30, 2022 | -20.74 Mn |
| Mar 31, 2022 | -66.46 Mn |
| Dec 31, 2021 | -2.33 Mn |
| Sep 30, 2021 | -17.08 Mn |
| Jun 30, 2021 | -5,325.00 |